Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

TEVA PHARMS

  • FDA Approval
  • April 30, 2024, 08:41 UTC
  • 45
  • 0 comments

FDA approve MIDOSTAURIN

Comment Full text

GRANULES

  • FDA Approval
  • April 30, 2024, 08:41 UTC
  • 42
  • 0 comments

FDA approve COLCHICINE

Comment Full text

X4 PHARMACEUTICALS INC

  • FDA Approval
  • April 29, 2024, 18:53 UTC
  • 46
  • 0 comments

FDA approve MAVORIXAFOR

Comment Full text

ABBVIE INC

  • FDA Approval
  • April 29, 2024, 15:42 UTC
  • 43
  • 0 comments

FDA approve UPADACITINIB

Comment Full text

AQUESTIVE THERAPEUTICS INC

  • FDA Approval
  • April 29, 2024, 12:01 UTC
  • 42
  • 0 comments

FDA approve DIAZEPAM

Comment Full text

TRIS PHARMA INC

  • FDA Approval
  • April 29, 2024, 04:31 UTC
  • 41
  • 0 comments

FDA approve DEFLAZACORT

Comment Full text

GLAND

  • FDA Approval
  • April 29, 2024, 04:31 UTC
  • 41
  • 0 comments

FDA approve CETRORELIX ACETATE

Comment Full text

TEVA PHARMS INTL

  • FDA Approval
  • April 26, 2024, 17:56 UTC
  • 49
  • 0 comments

FDA approve CYCLOBENZAPRINE HYDROCHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • April 26, 2024, 17:46 UTC
  • 45
  • 0 comments

FDA approve DIGOXIN

Comment Full text

TEVA

  • FDA Approval
  • April 26, 2024, 17:46 UTC
  • 45
  • 0 comments

FDA approve ZINC ACETATE

Comment Full text
  • Previous
  • 467
  • 468
  • 469
  • 470
  • 471
  • Next

Search

News categories

  • Technical Exchange News(11662)
  • Event(3945)
  • SEC News(229945)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(141247)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin